Who is WHO and what was REAL? A review of the new WHO classification (2001) for malignant lymphomas

Swiss Medical Weekly

Volumn 132, Issue 43-44, 2002, Pages 607-617

  Cogliatti, Sergio B ^a   Schmid, Ulrico ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Hodgkin lymphoma; Kiel; Lymphoma classification; Non Hodgkin lymphoma; REAL; WHO

Indexed keywords

B CELL LYMPHOMA; BONE MARROW CELL; CANCER CLASSIFICATION; CANCER GRADING; DENDRITIC CELL; HEMATOPOIETIC SYSTEM TUMOR; HODGKIN DISEASE; LYMPHATIC SYSTEM TUMOR; LYMPHOMA; MAST CELL; NODULAR LYMPHOMATOSIS; PROGNOSIS; SHORT SURVEY; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

EID: 0037079535     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (37)

1. Rappaport H. Tumors of the hematopoietic system. Atlas of Tumor Pathology, Sect 3, Fasc. 8. Armed Forces Institute of Pathology (AFIP) 1966: pp.97-8.
2. Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM. Classification of non-Hodgkin's lymphomas. (Letter to the Editor). Lancet 1974/II:406-8.
3. Lennert K, Feller AC. Histopathology of Non-Hodgkin's Lymphoma (according to the up-dated Kiel classification). Berlin: Springer; 1992.
4. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974;34:1488-1503.
5. Non Hodgkin's lymphoma pathologic classification project. National Cancer Institute (NCI) sponsored study of classifications of non-Hodgkin's Lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 1982;49: 2112-35.
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
7. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of Non-Hodgkin's lymphoma. Blood 1997;89: 3909-18.
8. Jaffe ES, Harris NL, Stein H, Vardiman JW, et al. World Health Organisation Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press; 2001.
9. Cogliatti SB, Lennert K, Hansmann M-L, Zwingers TL. Monocytoid B-cell lymphoma: clinical and prognostic features of 21 patients. J Clin Pathol 1990;43:619-25.
10. Schmid C, Kirkham N, Diss TC, Isaacson PG. Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992;16:455-66.
11. Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, Heinrich U, et al. The t(11;18)(q21;q21) chromosomal translocation is a frequent and specific aberration in low grade but not in high grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT)-type. Cancer Res 1997; 57:3944-8.
12. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl-10 is involved in t(1;14) (p22;q32) of MALT B-cell lymphoma and mutated in multiple tumour types. Cell 1999;96:35-45.
13. Dogan A, Du MQ, Aiello A, Diss TC, Ye HT, Pan LX, et al. Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone. Blood 1998;91:4708-14.
14. Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, et al. Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project. Hum Pathol 1999;30:263-8.
15. Schmid U, Karow J, Lennert K. Follicular malignant non-Hodgkin's lymphoma with pronounced plasmacytic differentiation: a plasmacytoma-like lymphoma. Virchows Arch (A) 1985; 405:473-81.
16. Goates JJ, Kamel OW, LeBrun DP, Benharroch D, Dorfman RF. Floral variant of follicular lymphoma. Immunological and molecular studies support a neoplastic process. Am J Surg Pathol 1994;18:37-47.
17. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol 1983; 1: 187-92.
18. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organisation for Research and Treatment of Cancer. Blood 1997;90:354-71.
19. Aguilera NSI, Tomaszewski M-M, Moad JC, Bauer FA, Taubenberger JK, Abbondanzo SL. Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases. Mod Pathol 2001; 14: 828-35.
20. Delsol G, Lamant L, Mariame B, Pulford K, Dastugue N, Brousset P, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the t(2;5) translocation. Blood 1997;89:1483-90.
21. Aliazadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403: 503-11.
22. Möller P, Moldenhauer G, Momburg F, Lammler B, EberleinGonska M, Kiesel S, et al. Mediastinal lymphoma of clear cell type is a tumour corresponding to terminal steps of B cell differentiation. Blood 1987;69:1087-95.
23. DiGiuseppe JA, Nelson WG, Seifter EJ, Boinott JK, Mann RB. Intravascular lymphomatosis: a clinico-pathologic study of 10 cases and assessment of response to chemotherapy. J Clini Oncol 1994;12:2573-9.
24. Cesarman E, Chang Y, Moore PS, Said JYV, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
25. Liebow AA, Carrington CB, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 1972;3:457-8.
26. Koita H, Suzumiya J, Ohshima K, Takeshita M, Kimura N, Kikuchi M, et al. Lymphoblastic lymphom expressing natural killer cell phenotype with involvement of the mediastinum and the nasal cavity Am J Surg Pathol 1997;21:242-8.
27. + precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002;26:852-62.
28. Matutes E, Garcia Talavera J, O'Brian M, Catovsky D. The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol 1986;64:111-24.
29. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukaemia. Blood 1991;78:3269-74.
30. Loughran TP. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
31. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, et al. The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66: 848-58.
32. Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, et al. Childhood Ki-1 1ymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986;68:1042-9.
33. + T-cell lymphoma. Am J Surg Pathol 1993;17:859-68.
34. Pileri S, Mazza P, Zinani P, Poggi L, Poletti G, Tuta S, et al. Ki-1 lymphoma and Hodgkin's disease (letter). Haematologica 1989; 74: 333-4
35. Kadin ME, Nasu K, Sako D, Said J, Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol 1985;119:315-25.
36. +) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000;96: 3681-95.
37. Ashton-Key M, Thorpe PA, Allen JP, Isaacson PG. Follicular Hodgkin's disease. Am J Surg Pathol 1995;19:1294-9.